Katie Ewer to Malaria Vaccines
This is a "connection" page, showing publications Katie Ewer has written about Malaria Vaccines.
Connection Strength
2.503
-
Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP. Sci Rep. 2018 02 21; 8(1):3390.
Score: 0.666
-
Cryopreservation-related loss of antigen-specific IFN? producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy. Vaccine. 2017 04 04; 35(15):1898-1906.
Score: 0.624
-
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants. Mol Ther. 2017 02 01; 25(2):547-559.
Score: 0.619
-
Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens. J Immunol. 2018 08 15; 201(4):1315-1326.
Score: 0.171
-
Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™. Vaccine. 2017 10 27; 35(45):6208-6217.
Score: 0.162
-
Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine. Infect Immun. 2017 03; 85(3).
Score: 0.155
-
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909. PLoS One. 2011; 6(7):e22271.
Score: 0.106